NCT05178043 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05178043
Title	GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma
Recruitment	Active, not recruiting
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Suzhou Kintor Pharmaceutical Inc,
Indications	hepatocellular carcinoma
Therapies	Ascrinvacumab + Nivolumab
Age Groups:	senior \| adult
Covered Countries	USA

Filter rows:

Showing 1 to 5 of 5 entries

Facility	City	State	Zip	Country	Details
City of Hope National Medical Center	Duarte	California	91010	United States	Details
Los Angeles Hematology Oncology Medical Group	Los Angeles	California	90017	United States	Details
Medical Oncology Associates	Spokane	Washington	99208	United States	Details
NYU Langone Health	New York	New York	10016	United States	Details
Renovatio Clinical	Houston	Texas	77056	United States	Details

Showing 1 to 5 of 5 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT05178043Clinical Trial Detail